These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 36142219)
21. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients. Reinold J; Farahpour F; Schoerding AK; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Buer J; Witzke O; Westendorf AM; Kehrmann J Front Cell Infect Microbiol; 2022; 12():848650. PubMed ID: 35521219 [TBL] [Abstract][Full Text] [Related]
22. The gut microbiota of gibbons across host genus and captive site in China. Lan LY; You YY; Hong QX; Liu QX; Xu CZ; Chen W; Zhu YD; Du XQ; Fan PF Am J Primatol; 2022 Mar; 84(3):e23360. PubMed ID: 35166397 [TBL] [Abstract][Full Text] [Related]
23. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. Wu Y; Cheng X; Jiang G; Tang H; Ming S; Tang L; Lu J; Guo C; Shan H; Huang X NPJ Biofilms Microbiomes; 2021 Jul; 7(1):61. PubMed ID: 34294722 [TBL] [Abstract][Full Text] [Related]
24. Comparison of reduced metagenome and 16S rRNA gene sequencing for determination of genetic diversity and mother-child overlap of the gut associated microbiota. Ravi A; Avershina E; Angell IL; Ludvigsen J; Manohar P; Padmanaban S; Nachimuthu R; Snipen L; Rudi K J Microbiol Methods; 2018 Jun; 149():44-52. PubMed ID: 29501688 [TBL] [Abstract][Full Text] [Related]
25. Evidence of possible SARS-CoV-2 vertical transmission according to World Health Organization criteria in asymptomatic pregnant women. Sevilla-Montoya R; Hidalgo-Bravo A; Estrada-Gutiérrez G; Villavicencio-Carrisoza O; Leon-Juarez M; Villegas-Mota I; Espino-Y-Sosa S; Monroy-Muñoz IE; Martinez-Portilla RJ; Poon LC; Cardona-Pérez JA; Helguera-Repetto AC; Ultrasound Obstet Gynecol; 2021 Dec; 58(6):900-908. PubMed ID: 34580942 [TBL] [Abstract][Full Text] [Related]
26. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients. Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467 [TBL] [Abstract][Full Text] [Related]
27. Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort. Galperine T; Choi Y; Pagani JL; Kritikos A; Papadimitriou-Olivgeris M; Méan M; Scherz V; Opota O; Greub G; Guery B; Bertelli C; BMC Infect Dis; 2023 Aug; 23(1):537. PubMed ID: 37596518 [TBL] [Abstract][Full Text] [Related]
28. NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy. Giugliano R; Sellitto A; Ferravante C; Rocco T; D'Agostino Y; Alexandrova E; Lamberti J; Palumbo D; Galdiero M; Vaccaro E; Pagliano P; Weisz A; Giurato G; Franci G; Rizzo F Microb Pathog; 2022 Apr; 165():105506. PubMed ID: 35358660 [TBL] [Abstract][Full Text] [Related]
29. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences. Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423 [TBL] [Abstract][Full Text] [Related]
30. Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model. Zhang Y; Ma Y; Sun W; Zhou X; Wang R; Xie P; Dai L; Gao Y; Li J J Med Virol; 2024 Jan; 96(1):e29336. PubMed ID: 38193530 [TBL] [Abstract][Full Text] [Related]
31. Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19. Trøseid M; Holter JC; Holm K; Vestad B; Sazonova T; Granerud BK; Dyrhol-Riise AM; Holten AR; Tonby K; Kildal AB; Heggelund L; Tveita A; Bøe S; Müller KE; Jenum S; Hov JR; Ueland T; Crit Care; 2023 Feb; 27(1):69. PubMed ID: 36814280 [TBL] [Abstract][Full Text] [Related]
32. Association of Maternal Perinatal SARS-CoV-2 Infection With Neonatal Outcomes During the COVID-19 Pandemic in Massachusetts. Angelidou A; Sullivan K; Melvin PR; Shui JE; Goldfarb IT; Bartolome R; Chaudhary N; Vaidya R; Culic I; Singh R; Yanni D; Patrizi S; Hudak ML; Parker MG; Belfort MB JAMA Netw Open; 2021 Apr; 4(4):e217523. PubMed ID: 33890989 [TBL] [Abstract][Full Text] [Related]
33. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220 [TBL] [Abstract][Full Text] [Related]
34. Dynamic colonization of gut microbiota and its influencing factors among the breast-feeding infants during the first two years of life. Li P; Chang X; Chen X; Tang T; Liu Y; Shang Y; Qi K J Microbiol; 2022 Aug; 60(8):780-794. PubMed ID: 35622224 [TBL] [Abstract][Full Text] [Related]
35. Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity. Gauthier NPG; Locher K; MacDonald C; Chorlton SD; Charles M; Manges AR PLoS One; 2022; 17(10):e0275815. PubMed ID: 36240246 [TBL] [Abstract][Full Text] [Related]
37. High abundance of butyrate-producing bacteria in the naso-oropharynx of SARS-CoV-2-infected persons in an African population: implications for low disease severity. Akorli J; Opoku M; Appiah-Twum F; Akpo MS; Ismail RY; Boamah GYK; Obeng-Aboagye E; Adu-Asamoah D; Donkor IO BMC Infect Dis; 2024 Sep; 24(1):1020. PubMed ID: 39304808 [TBL] [Abstract][Full Text] [Related]
38. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients. Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127 [TBL] [Abstract][Full Text] [Related]
39. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity. Zuo T; Liu Q; Zhang F; Yeoh YK; Wan Y; Zhan H; Lui GCY; Chen Z; Li AYL; Cheung CP; Chen N; Lv W; Ng RWY; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC Microbiome; 2021 Apr; 9(1):91. PubMed ID: 33853691 [TBL] [Abstract][Full Text] [Related]
40. Perinatal Antibiotic Exposure Affects the Transmission between Maternal and Neonatal Microbiota and Is Associated with Early-Onset Sepsis. Zhou P; Zhou Y; Liu B; Jin Z; Zhuang X; Dai W; Yang Z; Feng X; Zhou Q; Liu Y; Xu X; Zhang L mSphere; 2020 Feb; 5(1):. PubMed ID: 32075882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]